These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20576214)

  • 1. Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
    Huscher D; Pittrow D; Distler O; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Kowal-Bielecka O; Avouac J; Behrens F; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE;
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S47-52. PubMed ID: 20576214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
    Distler O; Behrens F; Pittrow D; Huscher D; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Furst DE;
    Arthritis Rheum; 2008 Jun; 59(6):867-75. PubMed ID: 18512721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
    Avouac J; Huscher D; Furst DE; Opitz CF; Distler O; Allanore Y;
    Ann Rheum Dis; 2014 Jan; 73(1):191-7. PubMed ID: 23349131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Khanna D; Distler O; Avouac J; Behrens F; Clements PJ; Denton C; Foeldvari I; Giannini E; Huscher D; Kowal-Bielecka O; Lovell D; Matucci-Cerinic M; Mayes M; Merkel PA; Nash P; Opitz CF; Pittrow D; Rubin L; Seibold JR; Steen V; Strand CV; Tugwell PS; Varga J; Zink A; Furst DE; ;
    J Rheumatol; 2009 Oct; 36(10):2356-61. PubMed ID: 19820225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary hypertension in connective tissue disease].
    Schwarz EI; Ulrich S
    Z Rheumatol; 2018 Apr; 77(3):219-230. PubMed ID: 29594374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
    Thakkar V; Nikpour M; Stevens WM; Proudman SM
    Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK; Corkill MM; Hart HH; Ng KP
    N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of EULAR recommendations for the treatment of systemic sclerosis.
    Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U;
    Ann Rheum Dis; 2017 Aug; 76(8):1327-1339. PubMed ID: 27941129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis - continuing progress in developing clinical measures of response.
    Furst D; Khanna D; Matucci-Cerinic M; Clements P; Steen V; Pope J; Merkel P; Foeldvari I; Seibold J; Pittrow D; Polisson R; Strand V
    J Rheumatol; 2007 May; 34(5):1194-200. PubMed ID: 17477486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative.
    Khanna D; Tan M; Furst DE; Hill NS; McLaughlin VV; Silver RM; Steen VD; Langer A; Seibold JR;
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-21-7. PubMed ID: 24295227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?
    Korman BD; Lachant DJ; Castelino FV
    Rheum Dis Clin North Am; 2023 May; 49(2):345-357. PubMed ID: 37028839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
    Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
    Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists.
    Gargani L; Voilliot D; D'Alto M; Agoston G; Moreo A; Serra W; Pieri F; Mori F; Wierzbowska-Drabik K; Matucci-Cerinic M; Moggi-Pignone A
    Heart Fail Clin; 2018 Jul; 14(3):271-281. PubMed ID: 29966626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.
    Mangat P; Conron M; Gabbay E; Proudman SM;
    Intern Med J; 2010 Jul; 40(7):494-502. PubMed ID: 19460060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
    Reed J; Pope J
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials.
    Humbert M; Singh M; Furst DE; Khanna D; Seibold JR
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v33-v37. PubMed ID: 28992168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
    Overbeek MJ; Groepenhoff H; Voskuyl AE; Smit EF; Peeters JW; Vonk-Noordegraaf A; Spreeuwenberg MD; Dijkmans BC; Boonstra A
    Respir Res; 2008 Oct; 9(1):68. PubMed ID: 18828919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
    Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
    Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.